Sterling Capital Management LLC Rapt Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 95 shares of RAPT stock, worth $149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95Holding current value
$149% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
118Shares Held
29MCall Options Held
867KPut Options Held
46.9K-
Vanguard Group Inc Valley Forge, PA3.16MShares$4.95 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$4.21 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$3.83 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.71 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$2.51 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $46.6M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...